Tate & Lyle and Manus Partner to Expand Access to all-Americas-Sourced and Manufactured Stevia Reb M

November 6, 2024 Tate & Lyle

Rooted in a joint commitment to accelerate sugar reduction, Tate & Lyle PLC (Tate & Lyle or the Company), a world leader in ingredient solutions for healthier food and beverages, and Manus, a leading bioalternatives scale-up platform, announced a strategic partnership, known as The Natural Sweetener Alliance, to expand access to natural sugar reduction solutions.

Tate & Lyle Introduces OPTIMIZER STEVIA 8.10 – a Groundbreaking Stevia Composition for Cost-Effective, Premium Sweetening

August 8, 2024 Tate & Lyle PLC

This innovative ingredient delivers the highly desired premium taste profile closest to sugar, even at high sugar replacement levels, while offering a more cost-effective solution than other premium sweeteners. 

Tate & Lyle Continues Transformation Journey With Launch of New Brand

February 15, 2023 Tate & Lyle

Tate & Lyle PLC, a world leader in ingredient solutions for healthier food and beverages, is pleased to announce the launch of its new brand.

Tate & Lyle Expands Sweetener Portfolio with ERYTESSE Erythritol

November 21, 2022 Tate & Lyle

Tate & Lyle PLC (Tate & Lyle) is pleased to announce a new addition to its sweetener portfolio – ERYTESSE™ Erythritol. Through a strategic partnership distribution agreement with a leading supplier of erythritol, this addition expands our ability to help customers deliver on consumer demand for healthier, sugar and calorie reduced products, and extends Tate & Lyle’s position as the world leader in ingredient solutions for healthier food and beverages.

KPS Capital Partners to Acquire Controlling Stake in Tate & Lyle’s Primary Products Business in North America and Latin America

July 13, 2021 Tate & Lyle PLC

KPS Capital Partners, LP announced today that it has entered into a definitive purchase agreement with Tate & Lyle PLC to acquire a controlling stake in its Primary Products business in North America and Latin America and its interests in the Almidones Mexicanos S.A de C.V and DuPont Tate & Lyle Bio-Products Company, LLC joint ventures, through a newly formed company, for an enterprise value of $1.7 billion.